跳至主要内容

Heparin versus Saline Solution for Locking of Totally Implantable Venous Access Port (TIVAP): Cohort Study of the First Kurdistan Series of TIVAP

Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=51365#.VGVczGfHRK0

Introduction: Totally implantable venous access port (TIVAP) is essential prerequisite for most of chemotherapy protocols. Flushing with 0.9% sodium chloride becomes an alternative to heparinized solution. As flushing and locking solutions are still controversial, this study was conducted to compare efficacy of heparinized solution versus normal saline solution for locking in ports TIVAP. Patients and Methods: Prospective Cohort study performed in teaching hospital Sulaymaniyah-University of Kurdistan, Iraq, including 384 TIVAP implanted in cancer and non-cancer patients. The study reports the TIVAP outcome in 2 groups of patients where 2 different solutions used for maintaining catheter’s patency by heparinized solution in group (A), versus normal saline for group (B). Results: In group A, the rate of complications was 8.2% (n = 16) while in group B complications rate was 7.9% (n = 15). Thrombosis in group A occurred in 1.03% of the cases and in group B was 1.57%. There were no significant differences between the two groups regarding the causes for unwanted removals of the TIVAP. Conclusions: The results of our study suggest that heparin has no role in preventing the early or late complications of TIVAP and we do not recommend using it as a locking solution.
Cite this paper
Baram, A. , Majeed, G. , Abdullah, H. and Subhi, A. (2014) Heparin versus Saline Solution for Locking of Totally Implantable Venous Access Port (TIVAP): Cohort Study of the First Kurdistan Series of TIVAP. Advances in Lung Cancer, 3, 67-74. doi: 10.4236/alc.2014.34010. 
 

[1] Teichgräber, U.K., Pfitzmann, R. and Hofmann, H.A.F. (2011) Central Venous Port Systems as an Integral Part of Chemotherapy. Deutsches Ärzteblatt International, 108, 147-54.
[2] Olivia, A., et al. (2012) Totally Implantable Central Venous Access Devices in Patients with Cancer: Experience in a Private Oncological Center. Cirugía y Cirujanos, 80, 400-404.
[3] Bertoglio, S., et al. (2012) Efficacy of Normal Saline Versus Heparinized Saline Solution for Locking Catheters of Totally Implantable Long-Term Central Vascular Access Devices in Adult Cancer Patients. Cancer Nursing, 35, E35-E42. http://dx.doi.org/10.1097/NCC.0b013e31823312b1
[4] Marcy, P.-Y. (2008) Central Venous Access: Techniques and Indications in Oncology. European Radiology, 18, 2333- 2344. http://dx.doi.org/10.1007/s00330-008-0981-2
[5] Bassi, K.K., Giri, A.K., Pattanayak, M., Abraham, S.W. and Pandey, K.K. (2012) Totally Implantable Venous Access Ports: Retrospective Review of Long Term Complications in 81 Patients. Indian Journal of Cancer, 49, 114-118. http://dx.doi.org/10.4103/0019-509X.98934
[6] Fernanda et al. (2008) Patients’ Perception Regarding the Use of a Long-Term Catheter. Revista da Escola de Enfermagem da USP, 42, 518-523.
[7] Krupski, G., Froschle, G.W., Weh, F.J. and Schlosser, G.A. (1995) Central Venous Access Devices in Treatment of Patients with Malignant Tumors: Venous Port, Central Venous Catheter and Hickman Catheter. Cost-Benefit Analysis Based on a Critical Review of the Literature, Personal Experiences with 135 Port Implantations and Patient Attitude. Chirurgie, 66, 202-207.
[8] Infusion Nurses Society (2011) Infusion Nursing Standards of Practice. Journal of Infusion Nursing, 34.
[9] Cesaro, S., et al. (2009) Prospective, Randomized Trial of Two Different Modalities of Flushing Central Venous Catheters in Pediatric Patients with Cancer. Journal of Clinical Oncology, 27, 2059-2065.
http://dx.doi.org/10.1200/JCO.2008.19.4860
[10] Michael et al. (2008) Treatment and Prevention of Heparin-Induced Thrombocytopenia: American College of Chest Physicians. Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 340-380. http://dx.doi.org/10.1378/chest.08-0677
[11] Hadaway, L. (2006) Heparin Locking for Central Venous Catheters. Journal of the Association for Vascular Access, 11, 224-231. http://dx.doi.org/10.2309/java.11-4-17
[12] Zaghal, A., Khalife, M., Mukherji, D., et al. (2012) Update on Totally Implantable Venous Access Devices. Surgical Oncology, 21, 207-215. http://dx.doi.org/10.1016/j.suronc.2012.02.003
[13] Jan, H.-C., Chou, S.-J., Chen, T.-H., et al. (2012) Management and Prevention of Complications of Subcutaneous Intravenous Infusion Port. Surgical Oncology, 21, 7-13.
http://dx.doi.org/10.1016/j.suronc.2010.07.001
[14] Araújo, C., Silva, J.P., Antunes, P., et al. (2008) A Comparative Study between Two Central Veins for the Introduction of Totally Implantable Venous Access Devices in 1201 Cancer Patients. European Journal of Surgical Oncology, 34, 222-226. http://dx.doi.org/10.1016/j.ejso.2007.04.003
[15] Rosett, W. and Hodges, G. (1980) Antimicrobial Activity of Heparin. Journal of Clinical Microbiology, 11, 30-34.
[16] LeDuc, K. (1997) Efficacy of Normal Saline Solution versus Heparin Solution for Maintaining Patency of Peripheral Intravenous Catheters in Children. Journal of Emergency Nursing, 23, 306-309.
http://dx.doi.org/10.1016/S0099-1767(97)90216-6
[17] Camp-Sorell, D. (2010) State of the Science of Oncology Vascular Access Devices. Seminars in Oncology Nursing, 26, 80-87. http://dx.doi.org/10.1016/j.soncn.2010.02.001
[18] Biffi, R., Orsi, F., Pozzi1, S., Pace, U., et al. (2009) Best Choice of Central Venous Insertion Site for the Prevention of Catheter-Related Complications in Adult Patients Who Need Cancer Therapy: A Randomized Trial. Annals of Oncology, 20, 935-940. http://dx.doi.org/10.1093/annonc/mdn701
[19] Kuter, D.J. (2004) Thrombotic Complications of Central Venous Catheters in Cancer Patients. The Oncologist, 9, 207- 216. http://dx.doi.org/10.1634/theoncologist.9-2-207
[20] Ahn, S.J., Kim, H.C., Chung, J.W., An, S.B., Yin, Y.H., Jae, H.J. and Park, J.H. (2012) Ultrasound and Fluoroscopy-Guided Placement of Central Venous Ports via Internal Jugular Vein: Retrospective Analysis of 1254 Port Implantations at a Single Center. Korean Journal of Radiology, 13, 314-323. http://dx.doi.org/10.3348/kjr.2012.13.3.314
[21] Karamustafaoglu, Y.A., Yagci, S., Kocal, S. and Yoruk, Y. (2013) Comparison of Implantable Central Venous Ports: Subclavian versus Juguler Access. Journal of Clinical and Analytical Medicine, 4, 495-498. http://dx.doi.org/10.4328/JCAM.1118
[22] Vandoni, R.E., Guerra, A., Sanna, P., Bogen, M., Cavalli, F. and Gertsch, P. (2009) Randomized Comparison of Complications from Three Different Permanent Central Venous Access Systems. Swiss Medical Weekly, 139, 313-316.
[23] Wang, Y.-F., Cherng, S.-C., Chiu, J.-S., et al. (2006) Application of Upper Extremity Radionuclide Venography as a Diagnostic Approach for Port-A Catheter Thrombosis. Journal of the Chinese Medical Association, 69, 358-363. http://dx.doi.org/10.1016/S1726-4901(09)70273-4
[24] Di Carlo, I., Cordio, S., La Greca, G., Privitera, G., Russello, D., Puleo, S. and Latteri, F. (2001) Totally Implantable Venous Access Devices Implanted Surgically: A Retrospective Study on Early and Late Complications. Archives of Surgery, 136, 1050-1053. http://dx.doi.org/10.1001/archsurg.136.9.1050
[25] Stein, M. and Wagner, R.H. (2005) Complications of Central Venous Access Devices Outcome Analysis of 2359 Implantations. Deutsche Medizinische Wochenschrift, 130, 1129-1132.
http://dx.doi.org/10.1055/s-2005-866798                    eww141114lx
标签：

评论

发表评论

此博客中的热门博文

Electron Spin and Proton Spin in the Hydrogen and Hydrogen-Like Atomic Systems

Read full paper at: http://www.scirp.org/journal/PaperInformation.aspx?PaperID=52202#.VIj7tMnQrzE Author(s) Stanisław Olszewski * Affiliation(s) Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland . ABSTRACT The mechanical angular momentum and magnetic moment of the electron and proton spin have been calculated semiclassically with the aid of the uncertainty principle for energy and time. The spin effects of both kinds of the elementary particles can be expressed in terms of similar formulae. The quantization of the spin motion has been done on the basis of the old quantum theory. It gives a quantum number n = 1/2 as the index of the spin state acceptable for both the electron and proton ...
发表评论
阅读全文

Incorporation of High-Altitude Balloon Experiment in High School Science Classrooms

High-altitude balloon is a balloon, filled usually with helium or hydrogen that ascends into an area called “near space” or stratosphere. The most common type of high-altitude balloons are weather balloons. Other purposes include use as a platform for experiments in the upper atmosphere. Modern balloons generally contain electronic equipment such as radio transmitters, cameras, or satellite navigation systems, such as GPS receivers. The mission of the High-Altitude Balloon Experiment (HABE) is to acquire supporting data, validate enabling technologies, and resolve critical acquisition, tracking, and pointing (ATP) and fire control issues in support of future space-based precision pointing experiments. The use of high-altitude balloons offers a relatively low-cost, low-vibration test platform, a recoverable and reusable payload, worldwide launch capability, and a 'near- space' emulation of the future space systems operational scenarios. More recently, several university...
1 条评论
阅读全文

Fermented Brown Sugar Residue Prolongs the Caenorhabditis elegans Lifespan via DAF-16

Fermented brown sugar residue (FBSR) is generated in the course of purifying biomass ethanol from the yeast fermentation products of brown sugar. It contains abundant nutrition and is used in various industrial applications including as fertilizer and feed. Meanwhile, brown sugar has attracted attention as a health food and is thought to prevent cardiovascular diseases, hypertension, and brain stem diseases. Furthermore, polyphenol, contained in brown sugar, reduces oxidative stress and inhibits glucose absorption. DAF-16 is a transcription factor regulated downstream of the insulin signaling pathway and is one of the main factors contributing to aging and lifespan in C. elegans . Therefore, to determine the precise roles of the DAF-16 transcription factor in stress tolerance and life span, it is necessary to elucidate the signaling pathways involved in DAF-16 activation. This study was designed to elucidate the molecular mechanisms controlling the physiological stress toleran...
发表评论
阅读全文